166 related articles for article (PubMed ID: 37324436)
1. Tri-element nanozyme PtCuSe as an ingenious cascade catalytic machine for the amelioration of Parkinson's disease-like symptoms.
Xu H; Ding X; Li L; Li Q; Li Z; Lin H
Front Bioeng Biotechnol; 2023; 11():1208693. PubMed ID: 37324436
[TBL] [Abstract][Full Text] [Related]
2. Application of Metal-Based Nanozymes in Inflammatory Disease: A Review.
Li R; Hou X; Li L; Guo J; Jiang W; Shang W
Front Bioeng Biotechnol; 2022; 10():920213. PubMed ID: 35782497
[TBL] [Abstract][Full Text] [Related]
3. Redox Trimetallic Nanozyme with Neutral Environment Preference for Brain Injury.
Mu X; Wang J; Li Y; Xu F; Long W; Ouyang L; Liu H; Jing Y; Wang J; Dai H; Liu Q; Sun Y; Liu C; Zhang XD
ACS Nano; 2019 Feb; 13(2):1870-1884. PubMed ID: 30753061
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
5. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
Giordano S; Darley-Usmar V; Zhang J
Redox Biol; 2014; 2():82-90. PubMed ID: 24494187
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Nanozyme Hydrogel with Mucosal Healing Activity for Single-Dose Ulcerative Colitis Therapy.
Cheng C; Cheng Y; Zhao S; Wang Q; Li S; Chen X; Yang X; Wei H
Bioconjug Chem; 2022 Jan; 33(1):248-259. PubMed ID: 34936326
[TBL] [Abstract][Full Text] [Related]
7. Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis.
Xu Y; Luo Y; Weng Z; Xu H; Zhang W; Li Q; Liu H; Liu L; Wang Y; Liu X; Liao L; Wang X
ACS Nano; 2023 Oct; 17(19):18732-18746. PubMed ID: 37768714
[TBL] [Abstract][Full Text] [Related]
8. Integrated cascade nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory therapy.
Liu Y; Cheng Y; Zhang H; Zhou M; Yu Y; Lin S; Jiang B; Zhao X; Miao L; Wei CW; Liu Q; Lin YW; Du Y; Butch CJ; Wei H
Sci Adv; 2020 Jul; 6(29):eabb2695. PubMed ID: 32832640
[TBL] [Abstract][Full Text] [Related]
9. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes.
Padilla-Godínez FJ; Ruiz-Ortega LI; Guerra-Crespo M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359841
[TBL] [Abstract][Full Text] [Related]
11. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
12. Carbogenic Nanozyme with Ultrahigh Reactive Nitrogen Species Selectivity for Traumatic Brain Injury.
Mu X; He H; Wang J; Long W; Li Q; Liu H; Gao Y; Ouyang L; Ren Q; Sun S; Wang J; Yang J; Liu Q; Sun Y; Liu C; Zhang XD; Hu W
Nano Lett; 2019 Jul; 19(7):4527-4534. PubMed ID: 31244237
[TBL] [Abstract][Full Text] [Related]
13. Single-Atom Nanozyme with Asymmetric Electron Distribution for Tumor Catalytic Therapy by Disrupting Tumor Redox and Energy Metabolism Homeostasis.
Liu Y; Wang B; Zhu J; Xu X; Zhou B; Yang Y
Adv Mater; 2023 Mar; 35(9):e2208512. PubMed ID: 36373624
[TBL] [Abstract][Full Text] [Related]
14. Oxygen vacancy-enhanced catalytic activity of hyaluronic acid covered-biomineralization nanozyme for reactive oxygen species-augmented antitumor therapy.
Zhou P; Wang Z; Chen H; Yu D; Dai C; Qiu Z; Gao F; Pan B; Yuan F
Int J Biol Macromol; 2023 May; 236():124003. PubMed ID: 36907306
[TBL] [Abstract][Full Text] [Related]
15. Nanozyme-based catalytic theranostics.
Zhang Y; Jin Y; Cui H; Yan X; Fan K
RSC Adv; 2019 Dec; 10(1):10-20. PubMed ID: 35492517
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
18. A Redox Modulatory Mn
Singh N; Savanur MA; Srivastava S; D'Silva P; Mugesh G
Angew Chem Int Ed Engl; 2017 Nov; 56(45):14267-14271. PubMed ID: 28922532
[TBL] [Abstract][Full Text] [Related]
19. The potential use of nanozyme in aging and age-related diseases.
Gorgzadeh A; Amiri PA; Yasamineh S; Naser BK; Abdulallah KA
Biogerontology; 2024 Aug; 25(4):583-613. PubMed ID: 38466515
[TBL] [Abstract][Full Text] [Related]
20. Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element.
Olivares D; Huang X; Branden L; Greig NH; Rogers JT
Int J Mol Sci; 2009 Mar; 10(3):1226-60. PubMed ID: 19399246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
